Anti-Human IL1B Recombinant Antibody(Canakinumab)

Product Information

Catalog Number	YR1159
Product Name	Anti-Human IL1B Recombinant Antibody(Canakinumab)
Molecular Name	Canakinumab
Alias	Anti-IL1B Recombinant Antibody, Research Grade Canakinumab
CAS Number	914613-48-2
Molecular Weight	145.2 kDa
Target	IL1B[Homo sapiens]
Isotype	IgG1 Kappa
Clonity	Monoclonal
Source	CHO Cells
Size	1mg, 5mg
Concentration	1mg/ml
Purity	>95% as determined by SDS-PAGE
Applications	FCM, IP, ELISA, Neut, FuncS, IF, IHC
Buffer	PBS, pH7.5
Background	Canakinumab (INN), sold under the brand name Ilaris is a medication for the treatment of systemic juvenile idiopathic arthritis (SJIA) and active Still's disease, including adult-onset Still's disease (AOSD). It is a human monoclonal antibody targeted at interleukin-1 beta. It has no cross-reactivity with other members of the interleukin-1 family, including interleukin-1 alpha.
Storage	It is recommended to aliquote and store at -20°C for long term storage. Avoid repeated freezing and thawing cycles.
Note	This product is for research use only.

Cat#	Product Name	Species	Host	Applications	Size	Price